Evidence map›Paper›PMID 31355303›Full record

ReviewNeurology(R) neuroimmunology & neuroinflammation2019

Strategies for treatment of childhood primary angiitis of the central nervous system.

Jocelyne Beelen, Susanne M Benseler, Anastasia Dropol, Brianna Ghali, Marinka Twilt

Open access · goldAbstract readReview
In one paragraph

Review in Neurology(R) neuroimmunology & neuroinflammation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jocelyne BeelenCumming School of Medicine (J.B., S.M.B., A.D.), University of Calgary, Alberta, Canada; Section of Rheumatology (S.M.B., M.T.), Department of Pediatrics, Alberta Children's Hospital, Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada; and University of Calgary (B.G.), Alberta, Canada.
Susanne M BenselerCumming School of Medicine (J.B., S.M.B., A.D.), University of Calgary, Alberta, Canada; Section of Rheumatology (S.M.B., M.T.), Department of Pediatrics, Alberta Children's Hospital, Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada; and University of Calgary (B.G.), Alberta, Canada.
Anastasia DropolCumming School of Medicine (J.B., S.M.B., A.D.), University of Calgary, Alberta, Canada; Section of Rheumatology (S.M.B., M.T.), Department of Pediatrics, Alberta Children's Hospital, Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada; and University of Calgary (B.G.), Alberta, Canada.
Brianna GhaliCumming School of Medicine (J.B., S.M.B., A.D.), University of Calgary, Alberta, Canada; Section of Rheumatology (S.M.B., M.T.), Department of Pediatrics, Alberta Children's Hospital, Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada; and University of Calgary (B.G.), Alberta, Canada.
Marinka TwiltCumming School of Medicine (J.B., S.M.B., A.D.), University of Calgary, Alberta, Canada; Section of Rheumatology (S.M.B., M.T.), Department of Pediatrics, Alberta Children's Hospital, Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada; and University of Calgary (B.G.), Alberta, Canada.
University of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Childhood primary angiitis of the CNS (cPACNS) is a devastating neurologic disease. No standardized treatment protocols exist, and evidence is limited to open-label cohort studies and case reports. The aim of this review is to summarize the literature and provide informed treatment recommendations. Methods: A scoping review of cPACNS literature from January 2000 to December 2018 was conducted using Ovid, MEDLINE, PubMed, Embase, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, Vasculitis Foundation, European Vasculitis Society, CanVasc, Google Scholar, and Web of Science. Potentially relevant articles were selected for full-text review using the STROBE checklist if they met the following inclusion criteria: (1) reported treatment, (2) addressed pediatrics, (3) focused on the disease of interest, (4) included ≥5 patients, (5) original research, and (6) full-length articles. Reviews, expert opinions, editorials, case reports with <5 patients, articles lacking treatment information, or non-English articles were excluded. A standardized assessment tool measured study quality. Treatment and outcomes were summarized. Results: Of 2,597 articles screened, 7 studies were deemed high quality. No trials were available so no meta-analysis was possible. Overall, treatment strategies recommended are induction with acute antithrombotic therapy subsequently followed by high-dose oral prednisone taper over 3-12 months and long-term platelet therapy. In angiography-positive progressive-cPACNS and angiography-negative-cPACNS, we also recommend 6 months of IV cyclophosphamide therapy, with trimethoprim/sulfamethoxazole as part of induction, and maintenance therapy with mycophenolate mofetil/mycophenolic acid. Conclusion: No grade-A evidence exists; however, this review provides recommendations for treatment of cPACNS.

Indexed as

Brain InjuriesChildCohort StudiesHumansImmunosuppressive AgentsMycophenolic AcidPlatelet Aggregation InhibitorsPrednisoneTrimethoprim, Sulfamethoxazole Drug CombinationVasculitis, Central Nervous SystemImmunosuppressive AgentsMycophenolic AcidPlatelet Aggregation InhibitorsPrednisoneTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID31355303
PMCPMC6624095
OpenAlexW2943542814

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.